ADIPOQ and atherosclerosis: Loss of FGF21 accelerates the plaque formation and the development of atherosclerosis in apoE KO mice, and administration with recombinant human FGF21 protein strongly attenuates the development of atherosclerosis in apoE KO mice by suppression of cholesterol synthesis and production of adiponectin (13, 31).